Vapotherm Inc (VAPO)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Joseph Army
Employees:
276
100 DOMAIN DRIVE, EXETER, NH 03833
603-658-0411

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Data derived from most recent annual or quarterly report
Market Cap 71.456 Million Shares Outstanding26.564 Million Avg 30-day Volume 461.412 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.52
Price to Revenue3.5986 Debt to Equity1.7892 EBITDA-61.6 Million
Price to Book Value6.8467 Operating Margin-65.6852 Enterprise Value392.817 Million
Current Ratio5.373 EPS Growth-0.463 Quick Ratio3.538
1 Yr BETA 1.429 52-week High/Low 31.87 / 2.46 Profit Margin-70.4939
Operating Cash Flow Growth-35.255 Altman Z-Score-1.3327 Free Cash Flow to Firm -66.957 Million
View SEC Filings from VAPO instead.

View recent insider trading info

Funds Holding VAPO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VAPO BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-06-22:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-06-03:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-24:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2021-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    75.7 Thousand total shares from 10 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ARNERICH ANTHONY L.

    • Director
    1,318,469 2022-06-13 9

    LANDRY JOHN SVP & CHIEF FINANCIAL OFFICER

    • Officer
    128,074 2022-05-24 5

    ARMY JOSEPH PRESIDENT AND CEO

    • Officer
    • Director
    736,079 2022-05-17 3

    BERRY LANCE A

    • Director
    27,649 2022-05-12 2

    LIKEN JAMES W

    • Director
    134,378 2022-05-11 3

    LAWRENCE BRIAN SVP & CHIEF TECHNOLOGY OFFICER

    • Officer
    148,700 2022-05-10 2

    RAMADE GREGOIRE SVP AND CHIEF COMM OFFICER

    • Officer
    86,114 2022-05-10 6

    MCKAY DOROTA CHIEF ACCOUNTING OFFICER

    • Officer
    25,935 2022-05-10 4

    MOYNIHAN MARY BETH

    • Director
    15,829 2022-01-01 2

    WEATHERMAN ELIZABETH H

    • Director
    192,515 2021-12-31 2

    SPENCE DONALD J

    • Director
    20,579 2021-12-31 2

    DUBE JOEL F. CHIEF ACCOUNTING OFFICER

    • Officer
    15,104 2021-09-10 2

    KNOWLES LORI LYNN

    • Director
    13,415 2021-07-21 1

    SMITH THOMAS W

    • 10% Owner
    • MEMBER OF SECTION 13(D) GROUP
    650,000 2021-06-24 0

    HAHN MARINA

    • Director
    No longer subject to file 2021-06-22 0

    WALROD NICHOLAS T.

    • 10% Owner
    No longer subject to file 2020-12-07 0

    3X5 PARTNERS, LLC

    • 10% Owner
    No longer subject to file 2020-12-07 0

    BLOUIN DAVID OFFICER

    32,090 2020-09-14 0

    PRESCOTT GENERAL PARTNERS LLC

    SMITH THOMAS W

    • 10% Owner
    • MEMBER OF SECTION 13(D) GROUPMEMBER OF SECTION 13(D) GROUP
    3,225,190 2020-09-04 0

    REYNOLDS CRAIG B

    4,118 2020-09-01 0

    PARDO GEOFF

    4,118 2020-09-01 0

    VAPOTHERM INVESTORS, LLC

    • 10% Owner
    No longer subject to file 2020-08-12 0

    ARMSTRONG J NEAL

    57,148 2020-01-02 0

    3X5 PARTNERS, LLC

    3X5 SPECIAL OPPORTUNITY FUND, L.P.

    VAPOTHERM INVESTORS, LLC

    • 10% Owner
    3,374,162 2019-12-31 0

    COOLIDGE JOHN OFFICER

    67,445 2019-09-05 0

    MCQUEEN MICHAEL OFFICER

    71,184 2019-08-12 0

    PARDO GEOFFREY B

    0 2019-07-24 0

    DAVIDSON MARC OFFICER

    70,490 2019-01-17 0

    BECKER LINDSAY OFFICER

    31,798 2019-01-17 0

    GILDE HEALTHCARE HOLDING B.V.

    • 10% Owner
    No longer subject to file 2018-11-16 0

    3X5 SPECIAL OPPORTUNITY FUND, L.P.

    • 10% Owner
    1,049,958 2018-11-16 0

    BRAUSER GREGORY COO

    • Officer
    323,420 2014-12-18 0

    FROHMAN SCOTT CEO

    5,050,000 2014-06-27 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    ARNERICH ANTHONY L. - Director by christine a. arnerich trust

    2022-06-14 16:24:01 -0400 2022-06-13 P 5,000 $2.82 a 48,898 indirect -8.6331 17.2662 17.2662 6 -9.3525 3

    ARNERICH ANTHONY L. - Director by anthony l. arnerich trust

    2022-06-02 16:28:05 -0400 2022-06-01 P 10,000 $3.06 a 53,374 indirect -4.4586 -2.8662 7.6433 4 -4.4586 2

    LANDRY JOHN - Officer SVP & CHIEF FINANCIAL OFFICER

    2022-05-24 16:37:00 -0400 2022-05-24 P 5,000 $2.90 a 128,074 direct 0.33 6.2706 10.8911 3 0.0 1

    ARMY JOSEPH - Director - Officer PRESIDENT AND CEO

    2022-05-18 16:34:31 -0400 2022-05-17 P 5,000 $3.36 a 735,579 direct 2.6059 -0.9772 2.9316 3 -3.2573 4

    ARNERICH ANTHONY L. - Director by christine a. arnerich trust

    2022-05-17 16:39:01 -0400 2022-05-16 P 5,000 $3.42 a 43,898 indirect -3.1546 -4.4164 0.0 1 -6.3091 5

    ARMY JOSEPH - Director - Officer PRESIDENT AND CHIEF EXECUTIVE

    2022-05-12 20:49:06 -0400 2022-05-12 P 10,000 $3.33 a 730,579 direct -6.5574 -13.9344 -21.5847 0.0 1 -31.1475 25

    BERRY LANCE A - Director

    2022-05-12 20:57:29 -0400 2022-05-12 P 15,673 $3.18 a 27,649 direct -6.5574 -13.9344 -21.5847 0.0 1 -31.1475 25

    ARNERICH ANTHONY L. - Director by christine a. arnerich trust

    2022-05-11 20:16:48 -0400 2022-05-11 P 5,000 $2.89 a 38,898 indirect 6.3953 -10.7558 -13.0814 6.3953 2 -26.7442 26

    LIKEN JAMES W - Director

    2022-05-11 20:26:06 -0400 2022-05-11 P 10,000 $2.98 a 134,378 direct 6.3953 -10.7558 -13.0814 6.3953 2 -26.7442 26

    LAWRENCE BRIAN - Officer SVP & CHIEF TECHNOLOGY OFFICER

    2022-05-12 21:06:41 -0400 2022-05-10 A 53,000 a 53,000 direct

    LANDRY JOHN - Officer SVP AND CHIEF FINANCIAL OFFICE

    2022-05-12 21:16:55 -0400 2022-05-10 A 53,000 a 53,000 direct

    RAMADE GREGOIRE - Officer SVP AND CHIEF COMM OFFICER

    2022-05-12 21:30:01 -0400 2022-05-10 A 53,000 a 53,000 direct

    MCKAY DOROTA - Officer CHIEF ACCOUNTING OFFICER

    2022-05-12 21:38:12 -0400 2022-05-10 A 14,000 a 14,000 direct

    ARNERICH ANTHONY L. - Director by anthony l. arnerich trust

    2022-05-11 20:16:48 -0400 2022-05-09 P 5,000 $3.32 a 43,374 indirect 6.3953 -10.7558 -13.0814 6.3953 2 -26.7442 26

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VAPOTHERM INC VAPO 2022-06-30 22:15:03 UTC 0.6263 0.9437 1300000
    VAPOTHERM INC VAPO 2022-06-30 21:45:03 UTC 0.5879 0.9821 1300000
    VAPOTHERM INC VAPO 2022-06-30 21:15:03 UTC 0.5879 0.9821 1300000
    VAPOTHERM INC VAPO 2022-06-30 20:45:03 UTC 0.5365 1.0335 1300000
    VAPOTHERM INC VAPO 2022-06-30 20:15:04 UTC 0.5365 1.0335 1300000
    VAPOTHERM INC VAPO 2022-06-30 19:45:03 UTC 0.5365 1.0335 1300000
    VAPOTHERM INC VAPO 2022-06-30 19:15:03 UTC 0.5365 1.0335 1300000
    VAPOTHERM INC VAPO 2022-06-30 18:45:04 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 18:15:04 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 17:45:03 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 17:15:03 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 16:45:04 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 16:15:03 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 15:45:03 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 15:15:03 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 14:45:03 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 14:15:03 UTC 0.3869 1.1831 1300000
    VAPOTHERM INC VAPO 2022-06-30 13:45:03 UTC 0.1467 1.4233 1300000
    VAPOTHERM INC VAPO 2022-06-30 13:15:03 UTC 0.1467 1.4233 1300000
    VAPOTHERM INC VAPO 2022-06-30 12:45:03 UTC 0.1467 1.4233 1300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund VAPO -4476.0 shares, $-62216.4 2022-03-31 N-PORT

    Elevate your investments